Organon Claimed Company
Organon is a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. We build upon our strong foundation of more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies and asthma.
We bring these important therapies around the world, with an international footprint that serves people in more than 140 markets. We believe the diversity of our business provides a sustainable engine of growth so we can continue to invest in and advance new medicines and treatments for women that are so urgently needed.
We are here for her health. read more
Rachel Stahler — Chief Information Officer at Organon
Executive Bio
Rachel Stahler is Organon’s Chief Information Officer. She leads Business Technology for the company to help Organon realize a better and healthier day for every woman. In her role, Rachel is driving digital capabilities across all aspects of Organon’s strategy to build value for the company’s offerings and customers.
Rachel joins Organon with two decades of global technology experience in the healthcare industry and a passion for bringing new medicines and solutions to patients in need. Most recently, Rachel served as CIO at Allergan. Previously, Rachel has also held CIO positions at Syneos Health, inVentiv Health and Optimer Pharmaceuticals. Earlier in her career, she held senior technology roles at Pfizer.
Rachel serves on the Board of Directors for NeoGenomics, a cancer diagnostics and pharma services company. She is a graduate of the University of Pennsylvania and received an M.B.A. from Columbia University.
Rachel joins Organon with two decades of global technology experience in the healthcare industry and a passion for bringing new medicines and solutions to patients in need. Most recently, Rachel served as CIO at Allergan. Previously, Rachel has also held CIO positions at Syneos Health, inVentiv Health and Optimer Pharmaceuticals. Earlier in her career, she held senior technology roles at Pfizer.
Rachel serves on the Board of Directors for NeoGenomics, a cancer diagnostics and pharma services company. She is a graduate of the University of Pennsylvania and received an M.B.A. from Columbia University.
Executive Team Culture Ratings from Organon Employees
TOP
5%
Organon's Executive Team scores in the Top 5%
of similar sized companies on Comparably
of similar sized companies on Comparably
Organon's Executive Team at a Glance
Based on 707 ratings, Organon's employees are very satisfied with their Executive Team and give them an “A+” or 90/100. On average, Men provided higher ratings for their Executive Team compared to Women. Also, the Design department thinks more highly of the Executive Team relative to the Sales department.
Organon's Executive Team ranks in the Top 5% of other companies in New York and Top 5% of other companies on Comparably that also have 5,001-10,000 Employees.
×